Sanofi Pasteur, TIV + H1N1, Pediatric Population

Condition:   InfluenzaInterventions:   Biological: Trivalent Inactivated Influenza Vaccine;   Biological: Inactivated H1N1 VaccineSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)Completed - verified December 2010
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials